The advanced alloy of the Driver MX2 and Driver OTW has greater strength and more radiopacity than stainless steel. A unique fusion pattern and ultra-thin struts combine to produce a low-profile system for increased trackability and flexibility. Smooth, edgeless, modular design of 10 crowns and short 1.0 mm elements increases deliverability. Proprietary Discrete Technology minimizes balloon overhang. Available on over-the-wire or the short-wire, low-profile MX2 delivery system with optional wire exchange capability.
Technology | June 29, 2006
Excellent Lesion Support, Coverage
Videos | Stents | September 11, 2018
This is an animation showing how the dedicated bifurcation stent developed by Advanced Bifurcation Systems (ABS) is d
News | Stents | January 25, 2018
Elixir Unveils Transformational DynamX Stent Featuring Adaptive Segments that Uncage the Stented Artery
January 25, 2018 – Elixir Medical Corporation, a leader in the development of breakthrough adaptive remodeling techno
News | Stents | November 24, 2017
November 24, 2017 – During a late-breaking session at the European Society of Cardiology (ESC) 2017 meeting, presente
News | Stents | November 10, 2017
Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology portfolio, which now...
Feature | Stents | November 08, 2017
November 8, 2017 – New results from the HARMONEE Japan/U.S.
News | Stents | October 27, 2017
CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of CeloNova's...
Technology | Stents | March 02, 2017
March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc.
News | Stents | January 13, 2017
January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OC
Feature | Stents | January 12, 2017 | Dave Fornell
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results
News | Stents | November 09, 2016
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin